The Rising Popularity of Hemp-Derived Cannabinoid Products: A Call for Increased Regulation and Research

A significant proportion of Americans are reportedly turning to hemp-derived alternative cannabinoid products, such as CBD, delta 8, CBG, and CBN. These products are not currently regulated by the federal government, leading to growing concerns regarding their safety and efficacy. A quarter of American adults have used these products in the past year, highlighting the need for more research and regulation in this area.

Use of Cannabinoids: A Common Practice But Buyer Beware

According to a report from WebMD, over a quarter of American adults used hemp-derived cannabinoid products in the past year to manage pain and improve sleep. These products are particularly popular among younger adults and those in states where cannabis use is not legal. However, concerns have been raised about the transparency of product labeling and consistency. The lack of regulation and laboratory testing for safety has been highlighted as a significant issue. Different individuals have reported varying experiences with different products, emphasizing the need for better regulations to protect consumers.

Gaining Momentum: The Need for Regulation Intensifies

As per BNN Breaking, the rising popularity of unregulated hemp-derived products, particularly Delta-8-THC, in the US, has led to intensifying calls for regulation to protect consumers. There is a clear disparity in product safety compared to regulated cannabis products and the regulatory landscape varies from state to state. The American Medical Association recommends expanding public health surveillance and regulation of emerging cannabinoids to protect consumers, especially adolescents and young adults.

Regulatory Proposals and Pushbacks

The 2024 legislative session in Missouri started with Senate Bill 984 that proposes to regulate cannabinoid products the same way as marijuana, including age restrictions. Despite pushback from the Missouri Hemp Trade Association, which argues that this could harm small businesses and entrepreneurs in Missouri, Senator Nick Schroer, who introduced the bill, believes that both cannabinoid and marijuana products should be under the same regulatory scheme. The bill is expected to be reviewed by the Public Safety Committee or the Health Care Committee by the end of the legislative session in May.

Hemp Industry's Call for Clarity and Support

The hemp industry is urging Congress to include provisions in the new farm bill that would permit the sale of hemp as a food additive and dietary supplement and increase the THC allowance for hemp plants. The lack of regulatory clarity from the FDA and the pandemic have posed significant challenges to the industry, resulting in substantial financial losses. The proposed farm bill should also clear hemp seed for use in feed for non-consumption animal species and make more laboratories eligible to test hemp crops for THC content.

In conclusion, the rising popularity of hemp-derived cannabinoid products calls for more comprehensive research into their safety and efficacy. There is an urgent need for increased regulation and standardization to ensure consumer safety. It is crucial for stakeholders, including lawmakers, health organizations, and the hemp industry, to work together to create a regulatory framework that balances consumer protection with industry growth.